article thumbnail

The Inflation Reduction Act: The Impact of Medicare Negotiation of Prescription Drug Prices on Hospitals and Health Systems

Electronic Health Reporter

The article The Inflation Reduction Act: The Impact of Medicare Negotiation of Prescription Drug Prices on Hospitals and Health Systems appeared first on electronichealthreporter.com. In August, H.R. 5376, the Inflation Reduction Act of 2022 (IRA), was passed via partisan votes by both chambers of Congress and […].

article thumbnail

Biden’s proposed HHS budget aims to make pandemic-era subsidies permanent

Healthcare Dive

Released Thursday, the budget also proposes to extend Medicare solvency and give the federal government more power to negotiate prescription drug prices.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Senate Dems reach draft deal to extend ACA premiums, lower drug costs

Healthcare Dive

The bill, part of a more than $300 billion package, extends enhanced ACA premiums and allows Medicare to negotiate select prescription drug prices starting in 2026.

ACA 263
article thumbnail

Waltz Health Enters Medicare Market to Deliver Prescription Drug Savings

HIT Consultant

What You Should Know: Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications, today announced its entry into the Medicare market. The struggle with out-of-pocket drug expenses affects millions of Medicare beneficiaries annually, particularly underserved groups.

article thumbnail

Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023

Health Law Advisor

To advance these efforts, CMS established a Medicare Drug Rebate and Negotiations Group dedicated to the IRA and set forth the agency’s intended overarching timeline to implement the various IRA provisions, such as the Medicare Drug Price Negotiation Program and the Part D redesign.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries. Reforming Patient Cost Sharing for Cancer Medications in Medicare Part D. New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges. Am J Prev Cardiol. 2022 Aug 2;11:100370. Lancet Oncol.

article thumbnail

Democrats Didn’t Achieve All Their Goals, but Inflation Reduction Act Makes Historic Medicare Changes

Kaiser Health News

First, it would give the federal government the ability to negotiate prices of some drugs purchased by Medicare beneficiaries, a tool that has long been opposed by the drug industry. Never before have we been able to negotiate prescription drug prices. Those prices would take effect in 2026.